Included in the formulation
АТХ:N.03.A.X.30 Byclamamide
Pharmacodynamics:Beclamide is an antiepileptic agent.The substance interacts with proteins and phospholipids contained in membranes neurons, breaks their permeability for sodium ions. Blocks the transmission of convulsive discharges.
Pharmacokinetics:No data.
Indications:Epilepsy of various genesis, generalized seizures; partial seizures.
Contraindications:Hypersensitivity to the body.
Carefully:It is necessary to monitor the function of the liver, kidneys, and biochemical blood indices for long-term admission.
Pregnancy and lactation:Contraindications to use during pregnancy and lactation.
Dosing and Administration:When ingested by adults - 500 mg 4 times a day, the dose is increased by 500 mg per day to 4 g per day, when absolutely necessary - sometimes 6 g per day. After achieving the optimal therapeutic effect, the dose can be reduced to a minimum effective dose.
Children are prescribed 250-500 mg 2-4 times a day, depending on the age, frequency of seizures and the child's response to treatment.
Side effects:From the central nervous system: dizziness, general weakness, sleep disturbances.
From the digestive system: development gastritis.
Overdose:Treatment is symptomatic. There are no data on overdose cases.
Special instructions:Currently, almost no use because of severe side effects, as well as low efficiency at small epileptic seizures, tonic convulsions.